Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003751 |
---|---|
Receipt number | R000004546 |
Scientific Title | A phase II feasibility trial of Gemcitabine Hydrochloride and Krestin combination therapy in pancreatic cancer after surgery. |
Date of disclosure of the study information | 2010/06/30 |
Last modified on | 2010/06/14 19:13:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/14 19:13:44 |